Article
Oncogene-targeted antisense oligonucleotides for the treatment of Ewing sarcoma
1 Aug 2005
Abstract excerpt
The genetic hallmark of the Ewing sarcoma family of tumours (ESFT) is the presence of the t(11;22)(q24;q12) translocation, present in up to 85% of cases of ESFT, which creates the EWS/FLI1 fusion gene and results in the expression of a chimeric protein regulating many other genes. The inhibition of this protein by antisense strategies has shown its predominant role in the transformed phenotype of Ewing cells. In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
